Universe Pharmaceuticals (UPC) Other Gross PP&E Adjustments (2020 - 2025)

Universe Pharmaceuticals' Other Gross PP&E Adjustments history spans 6 years, with the latest figure at $10.5 billion for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments rose 2.49% year-over-year to $10.5 billion; the TTM value through Sep 2025 reached $10.5 billion, up 2.49%, while the annual FY2025 figure was $10.5 billion, 2.49% up from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was $10.5 billion at Universe Pharmaceuticals, up from $10.2 billion in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $10.5 billion in Q3 2025 and bottomed at $9.8 million in Q3 2023.
  • The 5-year median for Other Gross PP&E Adjustments is $10.5 million (2021), against an average of $4.2 billion.
  • The largest annual shift saw Other Gross PP&E Adjustments decreased 4.79% in 2022 before it skyrocketed 104847.16% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $10.5 million in 2021, then fell by 4.79% to $10.0 million in 2022, then decreased by 2.11% to $9.8 million in 2023, then surged by 104847.16% to $10.2 billion in 2024, then grew by 2.49% to $10.5 billion in 2025.
  • Per Business Quant, the three most recent readings for UPC's Other Gross PP&E Adjustments are $10.5 billion (Q3 2025), $10.2 billion (Q3 2024), and $9.8 million (Q3 2023).